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BCG (Calmette-Gu6rin bacillus) is presumed to protect against tuberculosis 
by virtue of the specific immune response it provokes in the vaccinated subject, 
but the measurement of this response is beset with technicM problems. First, 
the  tubercle  bacillus,  against  which  specific  resistance  must  ultimately be 
measured, is a  poor indicator of the resistance  generated in  response to im- 
munization. Not only does it grow relatively slowly in the tissues of the nonim- 
mune host, but it is also discouragingly resistant to inactivation, even at the 
height of the immunity generated during infection. Second,  the  challenge in- 
fection itself provokes an immune response which may be prompt and  large 
enough to overshadow most of the effects of prior  immunization. As a  result, 
the observed differences between nonimmune and immunized animals are often 
small, regardless of whether they are estimated by bacterial enumeration or 
mortality data (1). 
These problems can be largely circumvented by using organisms other than 
the tubercle bacillus to measure the progressive changes in host resistance pro- 
duced by vaccination with BCG. This approach is made feasible by the very 
high  order  of cross-resistance  which  develops  between infections caused  by 
intracellular bacterial parasites. This phenomenon of cross-resistance is depend- 
ent upon the well documented observation that when the mononuclear phago- 
cytes of the infected host become highly resistant to infection their activities 
are not exclusively directed against the infective agent which induced the cel- 
lular change (2). 
In the present studies, Listerla monocytogenes and Salmonella  lypkimuriura 
have been used to measure the development of host resistance after primary 
BCG infection in the mouse and to study the effect of reinfection with BCG. 
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The  latter investigation was  undertaken  in  the belief that  the benefits of im- 
munization  may  rest  less  upon  the  level  of resistance  present  at  the  time  of 
reinfection  than  upon  the  capacity  of  the vaccinated  animals  to  produce  an 
anamnestic response. 
Materials and Methods 
Animals.--Female  mice from  a  specific pathogen-free  (SPF)  colony maintained  at  the 
Trudean Institute were used at 6-8 weeks of age. This colony was derived from Caesarian- 
obtained, barrier-sustained progenitors (COBS) supplied by Charles River Breeding Labora- 
tories, North Wilmington, Mass. They have been maintained in strict isolation in an infec- 
tion-free environment. 
Organisms.--The  strain of Listeria monocytogenes was virulent for SPF mice  (intravenous 
LI)50 =  3  X  104) in which viruienee was maintained by continuous passage.  Organisms re- 
covered from the spleen were used at the first subculture in tryptic soy broth (Dffeo Labora- 
tories Inc., Detroit, Mich.). Viable counts were performed on tryptic soy agar (Dffco). The 
strain of Salmonella typhimurlum  was also virulent for SPF mice (intravenous Ia)~0 =  2  X 
103). It was grown in trypfic soy broth and viable counts were made on nutrient agar plates 
(Difco). BCG (Rosenthal) and Mycobacterium smegmatis were obtained from the culture bank 
at the Trudean Institute, where stock cultures were maintained on an inspissated egg medium 
(3). Mice were infected with BCG using a 6-day growth from the second or third subculture 
in Tween-albumin liquid medium  (Difco). The BCG cultures were dispersed by ultrasound 
(Bronwill Biosouik)  and diluted in 0.01%  bovine serum albumin  (BSA)  in 0.85%  sodium 
chloride prior to injection. Plate counts were performed on Middlebrook 7H-10 agar (Difco). 
M. smegmatis was used as a  3-day subculture in Tween-albumin liquid medium, and viable 
counts were made on nutrient agar. 
Serum.--Antiserum to S. typhimurium  was obtained from mice which had been immunized 
with a heat-killed vaccine. Three doses of 109 bacterial cells were given at weekly intervals, 
the first and third by intravenous injection and the other intraperitoneally. The mice were 
bled 1 wk after the last injection. The serum was separated, sterilized by membrane filtration, 
stored at --20°C in small volumes, and used immediately after thawing. 
Bacterial Enumeration in Liver, Spleen and Blood.--Organs  removed aseptically from in- 
dividual mice were ground separately with a motor driven teflon-glass homogenizer in a final 
volume of 10 ml of 0.01% BSA in saline. Mter serial dilution in the same solution, aliquots 
were inoculated on suitable agar plates. The number of bacteria in circulation was estimated 
by plating approximately 0.1 ml of blood from the retro-orbital venous plexus on tryptic soy 
agar, and multiplying the colony count by 20, on the assumption that the blood volume of a 
mouse was approximately 2 ml. 
Bacteric~al  Activity  of Peritoneal Cdls.--A method was devised which employed M. smeg- 
matis as a stable viable marker which is readily phagocytosed by peritoneal macrophages and 
survives well within them (4). 
An 18 hr culture of S. typhimurium  was exposed to ultrasound for 10 see and the bacteria 
were counted in a  Petroff-Hansser chamber. The culture was then diluted in balanced saline 
solution (BSS) to a  concentration of 5  ×  106 bacilli/ml, and added to specific antiserum in 
the ratio of 4 to 1. This suspension was left at 4°C for 30 rain to ensure opsonization. Mean- 
while, aggregates were removed from a Tween-albumin culture of M. smegmatis by centrifu- 
gation before and after exposure to ultrasound for 10 see.  Mter direct counting and dilution 
in BSS to a concentration of 5  X  l0  s bacteria/ml, this suspension was mixed with an equal 
volume of a  1 : 10 dilution of the suspension of opsonized S. typhlmurlum  making a final sus- 
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injected intraperitoneally with approximately 5 X  104 mixed bacteria in a volume of 0.1 ml. 
Exactly 15 min later, the mice were killed and their peritoneal cavities were washed out with 
2 ml distilled water. Aliquots of appropriate dilutions of the original inoculum and the peri- 
toneal washings were plated in duplicate. Colonies of S. typhimurium  and M. smegmad~is were 
counted after 24 and 72 hr incubation at 37°C,  respectively. The two bacterial species were 
easily distinguishable by means of their different growth rates and colonial morphology. The 
results were expressed as the "corrected percentage survival" of S. typhimurium,  which was 
calculated as follows: 
100 X 
(Viable count S. typhimurium /viable count M. smegmatis)  recovered 
(Viable count S. typhimurium/viable count M. smegmatis)  injected 
The use of the above ratio ensured that the estimated survival of S. typMmuriam  was un- 
affected by such experimental variables as faulty inoculation, transport  of organisms from 
the peritoneal cavity, or incomplete recovery of the inoculum from the peritoneal cavity. 
The method described is dependent  on two  assumptions,  namely:  (a)  The bacterial in- 
oculum is rapidly phagocytized after its introduction into the peritoneal  cavity. In a  pre- 
liminary experiment it was found that the mean percentage phagocytosis at 15 rain was 99.9% 
for S. cyphimurCura and 96.3% for M. smegmatis. (b) No appreciable killing of M. smegmatis 
occurred during the period of observation. Preliminary tests showed that no measurable re- 
duction occurred over a 4 hr period in the number of viable M. smegmatis present in the livers 
or spleens of mice inoculated intravenously. 
These results  are consistent with those of Cohn  (4)  who found  that  M. smegmatls was 
rapidly phagocytized by peritoneal cells, yet survived well within them. 
Mouse Maerophage Cultures and Elearonmicroscopy.--Mouse  peritoneal macrophages were 
obtained in suspension  by washing out the peritoneum with  Hanks'  BSS containing  10% 
fetal calf serum (FCS) and 2 units/ml heparin. Aliquots were placed in simple well chambers 
made from a glass ring fixed to a coverglass. They were incubated at 37°C in an atmosphere 
containing 5% COs. After appropriate intervals, cultures were fixed for 10 rain with 1.5% 
glutaraldehyde in 0.67  ~  eacodylate buffer  (pH 7.4)  and  1% sucrose.  They were examined 
by phase microscopy. Peritoneal cells were also fixed in suspension with the same glutaralde- 
hyde fixative and postfixed with 1% osmium tetroxide in 0.05  ~s acetate-veronal buffer and 
5% sucrose at pH 7.4. They were then embedded in Epon, sectioned, and stained with uranyl 
acetate and lead citrate for electron microscopic examination. 
Delayed Rypersensi~vity  in the Footpad.--2  #g PPD  (purified  protein derivative)  (Parke, 
Davis and Co., Detroit, Mich.) was injected in a volume of 40 #1 diluent (Parke, Davis) into 
the right hind footpad. After 24 hr, the thickness of each hind foot was measured to 0.05 mm 
with dial gauge calipers (Schnelltaster, H. C. KrSplin, GmbH, Schiuchtern, Hessen, Germany). 
Since it has been shown that the right and left hind feet of the mouse do not differ insize (5), 
the difference  between them served as a  measure of delayed hypersensitivity. The observed 
reaction had the following characteristics. It began at about 3-6 hr, reached a peak at 24 hr, 
and  subsided  gradually over the next 4  days.  Histologically the cellular infiltrate was pre- 
dominantly mononuclear in character and reactivity could be transferred to normal recipients 
with 10  s spleen cells from a sensitive donor, but not with immune serum in amounts equiva- 
lent to the circulating blood volume. The reaction thus fulfilled all of the criteria by which 
delayed-type hypersensitivity is recognized. 
General Procedure.--At  intervals after primary and secondary infection, BCG mice from 
each experimental group were used in a variety of tests: (a)  The level of delayed hypersensi- 
tivity was measured in 10 mice injected with PPD 24 hr previously. (b)  Five mice were in- 
jected intraperitoneally with the suspension of S. typhimurium  and M. smegmatis to measure 1082  HOST RESP01~SE TO CALMETTF.-GU~RIN  BACILLUS 
bactericidal activity in peritoneal macrophages. (c) 10 rain later, approximately 10  6 L.  mono- 
cytogenes in 0.2 ml BSS were inoculated intravenously into the five mice from (b) and an addi- 
tional five mice. (d) 5 rain after the challenge with L. monocytogenes, the 5 mice of (b) were 
bled from the retro-orbital venous plexus and killed by cervical dislocation. The peritoneal 
cavity was washed out (bactericidal activity of peritoneal cells) and the liver and spleen re- 
moved to estimate the viable counts of L. monocytogenes and BCG. (e) The remaining five 
mice were killed 24 hr later and the liver and spleen were removed to obtain viable counts of 
L. monocytogenes. 
The viable count of L. monocytogenes or BCG from each mouse organ or blood was trans- 
formed to the logl0 and the results from each group of mice were expressed as the geometric 
mean value to the logxo. Unless otherwise stated, all means quoted refer to groups of five mice, 
except for the delayed hypersensitivity tests which were done on groups of 10 mice. 
RESULTS 
Host Response to Primary Infection witk BCG 
Three groups of mice were used: a group of unvaccinated controls (group I), 
and  two groups of vaccinated mice which  received low (group II) and  high 
(group III) doses of BCG intravenously. Viable counts showed that the latter 
groups received 4  X  103 and 4  X  106 viable BCG,  respectively.  Batches of 
five mice from each group were tested  for resistance to Listeria challenge at 3 
day intervals during the first  15 days of the experiment,  at weekly intervals 
until the 35th day, and finally on the 56th day. 
The mean viable counts of L. monocytogenes  obtained from the liver, spleen, 
and blood of mice 5 rain after intravenous challenge are shown in Table I. The 
mean derived from each group of BCG-infected mice was compared with the 
corresponding mean from the control mice using the t test. 
As early as the 6th day after infection with BCG, there was a  highly sig- 
nificant decrease  (P  <  0.01)  in the number of viable L. monocytogenes  in the 
blood of the high dose mice of group III when compared with controls. The 
increased rate of clearance of Listeria in these animals reached a maximum on 
the 15th day, after which there was a gradual waning of the effect. The viable 
counts of L. monocytogenes  in the blood of control and low dose mice, though 
more similar,  were  usually lower in  the  latter.  The differences were  seldom 
significant (Table I), but comparison of the means of the pooled data derived 
from the whole experiment did yield  a significant difference (P <  0.05). This 
confirmed the impression that mice receiving the low dose of BCG also cleared 
L. monocytogenes  from the blood somewhat more efficiently than normal con- 
trols. 
It is evident from Table I  that  there was little  difference between  the  con- 
trol mice of group I and low dose mice of group II with respect to the numbers 
of Listeria implanted in the liver, but the viable counts from the livers of high 
dose mice (group III) tended to be lower than in the livers of control mice and 
such differences were sometimes significant. However, the difference between R.  V.  BLANDEN,  M.  J'.  I.EFFORD,  AND  G.  B.  MACKANESS  1083 
the means of the pooled data was small and nonsignificant, suggesting that the 
observed differences were due to experimental  variation. Similarly,  there was 
no material difference between  the counts of L. monocytogenes in the spleens 
of the control and low dose mice. However,  commencing on the 6th day, the 
counts from the spleens of the high dose mice were invariably higher than those 
in controls, reaching a maximum difference on the 15th day. Although the mag- 
TABLE I 
Primary Infection with BCG: Distribution of L. monocytogenes in Blood,  l_,iver, and Spleen of 
Mice 5 Min  after Intravenous  Challenge with Listeria 
Mean viable counts of L. raor,  ocytog6nes  (logto) 
Blood  Liver  Spleen 
Day of Lister~ 
challenge  after BCG  Group  Group  Group 
infection 
III  I  II  HI  I  III 
3 
6 
9 
12 
15 
21 
28 
35 
56 
Means of pooled 
data .......... 
I 
Normal 
mntrols 
3.27 
3.63 
3.23 
3.73 
4.01 
3.87 
3.66 
3.83 
3.63 
H 
4X  10s 
BCG 
3.20 
3.31 
3.875 
3.57 
3.76 
3.09* 
3.21 
3.35 
3.43~ 
4 X  10  6 
BCG 
2.96 
2.76" 
2.47" 
2.48* 
2.41" 
2.43* 
2.73" 
2.97* 
2.66* 
Normal 
controls 
5.05 
5.28 
5.55 
5.48 
5.26 
5.58 
5.28 
5.56 
5.05 
5.34 
4 X 10  ~ 
BCG 
5.04 
5.21 
5.54 
5.55 
5.24 
5.53 
5.26 
5.52 
4.945 
5.31 
4 X  10' 
BCG 
5.12 
5.18 
5.57 
5.45 
5.22 
5.42" 
5.15~ 
5.26 
4.965 
5.26 
Normal 
con trol~. 
3.88 
3.98 
4.42 
4.46 
4.12 
4.35 
4.39 
4.44 
3.62 
4.18 
H 
4 10  s 
BCG 
3.81 
4.04 
4.34 
4.29 
4.21 
4.47~ 
4.10 
4.41 
3.9o5 
4.18 
4 X  106 
BCG 
3.89 
4.22~ 
4.58~ 
4.67 
4.60* 
4.59* 
4.35 
4.65 
3.99' 
4.39~ 
* P  <  0.01\ When group I  was compared 
P  <  0.05J with group II or group III in t tests. 
nitude of these differences was variable,  the means derived from the pooled 
data did differ significantly  (P  <  0.05). These small differences in clearance 
rates and initial distribution of organisms  between liver and spleen,  though 
not very meaningful in themselves, were a minor reflection of the much larger 
differences found in the subsequent growth of Lisleria  in mice belonging  to 
different groups. 
The levels of host resistance to Listeria in the experimental  groups was esti- 
mated by comparing the increase in the number of Listeria during a 24 hr period 
in the livers and spleens of control mice with the corresponding increase found 
in the BCG-infected mice.  For each group the mean viable count (log10) of 
L. monocytogenes obtained at 5 rain was subtracted from the corresponding 24 1084  HOST  RESPONSE  TO  CALMETTE-GUI6-RIN BACILLUS 
TABLE II 
Mean Viable Counts of L. monocytogenes in the Livers and Spleens of Normal and BCG-Infected 
Mice, with Indices of Resistance 
Live r  Spleen 
Day of 
Listerla  Mean  viable counts of  Index of  Ioadex of 
challenge  Group*  L. rae~ocytegenss  Geometric  resistance  resistance  after BaG  0ogx0)  infection  increase  between  P  between 
in 24 hr  groups:  groups: 
I-II I-IH  I-II I-Ill  5 min  24 hr 
I  5.05  7.03  1.98 
II  5.04  7.12  2.08  -0.10  N.S.$  --0.37 
III  5.12  6.70  1.58  0.40  <0.05  0.19 
N.8. 
N.S. 
I  5.28  7.35  2.07 
II  5.21  7.25  2.04  0.03  N.S.  0.04 
III  5.18  6.09  0.91  1.16  <0.01  1.01 
N.S. 
<0.01 
I  5.55  7.68  2.13  -- 
II  5.54  7.15  1.61  0.52  N.S.  0.10 
III  5.57  4.56  --1.01  3.14  <0.01  2.75 
N.S. 
<0.01 
12  I  5.48  7.62  2.14 
II  5.55  6.74  1.19  0.95  0.01  0.14 
III  5.45  4.04  --1.41  3.55  <0.01  3.13 
N.S. 
<0.01 
15  I  5.26  7.25  1.99 
II  5.24  6.21  0.97  1.02  <0.01  0.44 
III  5.22  4.04  --1.18  3.17  <0.01  3.46 
<0.05 
d0.01 
21  I  5.58  7.43  1.85 
II  5.53  6.06  0.53  1.32  <0.01  0.64 
III  5.42  5.34  0.08  1.93  <0.01  2.35 
<0.01 
<0.01 
28  I  5.28  7.51  2.23 
II  5.26  6.54  1.28  0.95  <0.01  0.40 
III  5.15  5.99  0.84  1.39  <0.01  1.61 
S.S. 
<0.01 
35  I  5.56  7.54  1.98  -- 
II  5.52  6.54  1.02  0.96  <0.01  0.58 
III  5.26  5.94  0.68  1.30  <0.01  1.66 
<0.01 
<0.01 
56  I  5.05  6.59  1.54  -- 
II  4.94  5.88  0.94  0.60  <0.05  0.65 
III  4.96  5.22  0.26  1.28  <0.01  1.71 
<0.01 
<0.01 
* Group I, normal controls; group II, 4  X  103 BCG; group III, 4 >(  106 BCG. 
J; N.S. Statistically nonsignificant, P  >  0.05. R.  V.  BLANDEN,  M.  J.  LEF~'ORD, AND  G.  B.  MACKANESS  1085 
hr value, to give the geometric  increase  (or, in some cases, decrease)  in the 
number of Listeria during the 24 hr period. The geometric increases calculated 
for mice of the two infected groups were then separately subtracted from the 
corresponding control values to provide a measure of host resistance called the 
index of resistance. The method of calculating the indices of resistance from the 
liver  data is demonstrated in Table II. The corresponding  spleen results are 
expressed as indices of resistance  only, omitting the mean viable counts. The 
statistical significance of each index of resistance was tested by estimating its 
departure from zero by an analysis of variance. 
As early as the 3rd day after infection with BCG, the index of resistance for 
the livers of the high dose mice of group III was 0.40 log units (P <~ 0.05), and 
increased progressively to a peak of 3.17 log units on the 12th day. The index 
declined rapidly between the 15th and 28th days to 1.39 log units, at which 
level it remained fairly steady until the end of the experiment (Fig. 1, middle 
panel). Resistance to L. rntmocytogenes developed  a  little more slowly in the 
spleen. Significant resistance  first appeared on the 6th day, attained a maxi- 
mum value of 3.46 log units on the 15th day, and then fell rapidly in parallel 
with the liver indices (Fig. 1). 
Host resistance  in low dose mice of group II developed much more slowly 
and did not differ significantly from normal until the 12th day in the liver, and 
the 15 day in the spleen (Fig. 1 and Table II). Peak resistance was reached on 
the 21st day, but the indices of 1.32 and 0.64 log units in liver and spleen, re- 
spectively,  were much lower than those found in the high dose mice of group 
III. Despite this, a small but significant level of resistance persisted  until the 
56th day. 
The growth curve of BCG in the livers and spleens of mice infected with the 
larger dose are shown in the upper panel of Fig. 1. The highest counts were ob- 
tained on the 12th day of infection, corresponding to the peak of resistance to 
L. monocflogenes. Subsequently,  the number of viable BCG declined as resis- 
tance to L. monocytogenes was waning.  Because of technical errors the BCG 
counts in mice infected with the lower dose were fragmentary, and are not re- 
ported here. 
An in vitro method, other than that described  in Materials and Methods, 
was used to test the bactericidal  activity of peritoneal macrophages  from the 
3rd to the 12th day of the experiment.  It was found to be unsatisfactory so 
that data for this period are not available. However, the assay procedure using 
a combined inoculum of S. typhimurium and M. smegmatis, which was adopted 
on the 15th day, did not reveal any significant differences from normal in the 
macrophages  of mice infected with either dose of BCG, even though the 15th 
day corresponded  to the time of peak resistance  in the liver  and spleen.  In 
keeping with this finding, at no time did the peritoneal macrophages show any 
of the morphological  changes which  are associated  with an increase  in their 
microbicidal activity (see later section). \ 
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FzG. 1.  Top: Growth curves of BCG in the livers and spleens of mice given 4 X 10  e viable 
BCG intravenously. Middle:  Curves  depicting  the progressive changes in the index of re- 
sistance to L. monoeylogenes in the livers and spleens of mice during a primary infection with 
BCG at two dose levels. Bottom: Levels of delayed hypersensitivity (expressed as increase in 
foot thickness 24 hr after injection of PPD) found in the BCG infections depicted above. Each 
point represents the mean of a group of 5 mice (10 in the case of footpad tests). 
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The development of delayed hypersensitivity is depicted in the bottom panel 
of Fig.  1. Mice infected with the larger dose of BCG exhibited a  biphasic re- 
sponse. Hypersensitivity increased steadily until the 12th day when the num- 
ber of viable BCG and resistance to L. monocytogenes were near their maxima 
in the liver and spleen. As the BCG population in these organs began to decline, 
hypersensitivity decreased temporarily before returning  to  a  sustained  high 
level. Mice  receiving 4  X  10  s BCG became  equally hypersensitive without 
showing a  period of desensitization, but a  high level of hypersensitivity was 
not sustained in these mice. It had fallen to a low ebb by the 55th day when 
the remaining mice of this group were introduced into the reinfection experi- 
ment which follows. 
Response to Reinfection with BCG (Experiment  1) 
On the 55th day the remaining mice which had been infected with the lower dose of BCG 
were divided into two equal groups, one of which was reinfected  intravenously with 5 X l0  T 
viable BCG. At the same time, half of a group of normal mice received the same large dose 
of BCG. This created 4 groups: group I, normal controls; group II, mice which had received 
only the first injection of BCG 55 days previously;  group III, infected controls  which received 
only the reinfecting dose of BCG; and group IV, which received both the immunizing and 
reinfecting doses of BCG. Mice from each group were used at daily intervals over the next 5 
days to measure the level of resistance to L. monocytogenes in liver and spleen, the bactericidal 
activity of peritoneal macrophages, and the level of delayed hypersensitivity to PPD. 
Resistance  to L. monocytogenes in  the livers and  spleens  of BCG-infected 
mice (groups II, III, and IV) was again expressed as indices of resistance rela- 
tive to normal mice (group I). In addition, the resistance of mice which had 
been twice infected with  BCG  (group IV)  was  expressed as  indices of resis- 
tance relative to mice which had received only the small immunizing dose of 
BCG (group II), as shown in columns 4 and 6 of Table III. 
The indices of resistance in the livers and spleens of the immunized mice of 
group II were slightly increased throughout the experiment (Table III). On 
day 2, the indices of resistance in the rivers of the infected controls (group III) 
and  the  reinfected mice of  group  IV  were significantly increased,  and  con- 
tinued to rise in parallel until the end of the experiment (Fig. 2A). When the 
liver indices between groups I  and III and between groups II and IV were 
compared  (Table III),  it  appeared  that  prior immunization  with  BCG had 
conferred no advantages. 
Increased resistance to L. monocytogenes in the spleen was detected in the in- 
fected control mice of group III on day l, increased rapidly to 2.47  log units 
on day 2,  and  then remained fairly steady at  approximately the same level 
throughout the 3rd, 4th, and 5th days (Fig. 2C). Resistance in the spleens of 
the reinfected mice of group IV increased at approximately the same rate as 
in infected controls (group III) for the first 3 days, then continued to rise, so 
that on the 4th and 5th days the indices of resistance between groups II and IV 
were clearly greater than between groups I  and III (Table III). 1088  HOST RESPONSE TO  CAL~LETTE-GU~RIN  BACILLUS 
The  results  obtained  from  testing  the  bactericidal  activity  of  peritoneal 
macrophages were evaluated  by analysis  of variance.  The significance of the 
differences  between  the  normal  and  infected  controls,  and  between  the  ira- 
TABLE  III 
Indices  of Resiotance in Livers and Spleens of Mice after Primary and Secondary Infect4ons 
with BCG (Experiment 1) 
Day of Listerla~ 
challenge after~ 
first (or second)~1 
BCG infection 
56 (I) 
57  (2) 
58 (3~ 
59 (4) 
(s) 
Group* 
II 
III 
IV 
II 
III 
IV 
II 
III 
IV 
II 
III 
IV 
II 
III 
IV 
Liver 
Index of resistance calculated 
between groups 
I-II 
I-IIl 
I-IV 
0.60:~ 
0.20 
0.46 
o.83§ 
2.16§ 
2.41§ 
0.59~ 
2.57§ 
2.71§ 
H-IV 
--0.14 
1.58§ 
2.12§ 
2.40 
3.74§ 
Spleen 
Index of re,stance calculated 
between groups 
I-II 
I-III 
I-IV 
0.655 
0.90§ 
0.97§ 
0.675 
2.47§ 
2.50§ 
0.595 
2.20§ 
2.54§ 
o.81§ 
2.s8§ 
3.21§ 
0.18 
3.42§ 
3.92§ 
0.645 
2.17§ 
3.66§ 
0.06 
2.77§ 
3.83§ 
II-IV 
0.32 
1.83 
1.95§ 
3.02§ 
3.77§ 
* Group II, 4 X  103 BCG; group III, 5 
BCG. 
~t P o.o5. 
§ P  0.ol. 
X  10  7 BCG; group IV, 4 X  10  3BCG +  5 X  10  7 
munized and reinfected mice was tested at the 5 % level as indicated in Table 
IV. The mean  corrected  survival of S.  typhimurium  was approximately 50 % 
in normal  mice on each  of the first 4  days.  This level  of survival  is  usually 
found in normal mice, so that the low value of 33.1% obtained on the 5th day 
is  attributable  to  experimental  variation.  There  was  no significant  variation 
between the four mouse groups on the first day. The survival of S. typkimurium 
in reinfected mice (group IV) on the 2nd day was  18.8%,  which differed sig- R.  V.  BLANDEN~ ~I.  J.  LE~FFORD~ AND  O.  B.  MACKANESS  1089 
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FIG. 2.  The results of two experiments showing progressive changes in the index of re- 
sistance to L. monocytogenes in livers and spleens of mice during primary  and  secondary  in- 
fections with BCG. Experi~nt 1. A and C show the resistance  of liver and  spleen  in  mice 
immunized with 4 X  103 BCG 55 days prior to day 0 (group II) ; infected with 5 X  107 BCG 
on day 0 (group III); or immunized as in group II and reinfected on day 0 with 5 X  107 BCG 
(group IV). Exp~'imcn~ 2.  B  and  C  show resistance of liver and spleen in mice which had 
been: immunized with 1 X  104 BCG 23 days prior to day 0  (group II); infected with 1 X 
107 BCG on day 0 (group HI) ; or immunized with BCG as in group II and reinfected on day 
0 with 1 X  107 BCG (group IV). 1090  HOST  RESPONSE  TO CALMETTE-GI/ERIN  BACILLUS 
nificantly from the values obtained in  the normal and infected controls but 
not from that found in the immunized mice of group II. Between days 3 and 5, 
however, the differences between the immunized and the reinfected mice be- 
came statistically significant. By contrast, the peritoneal cells of infected con- 
trol mice (group III) showed no increase in microbicidal activity until day 5. 
At the beginning of the experiment, the animals  of group II had been in- 
fected with BCG for 55 days. By this time, the level of delayed hypersensitivity 
in them had fallen to a low level; the tuberculin test produced a mean increase 
in footpad thickness of 0.24 mm. The injection of 5 X  107 BCG into these mice 
TABLE  IV 
Surz'i~al of S. typhimurium in the Peritoneal Macrophages of Mice after Primary or Secondary 
Infection with BCG (Experiment  1) 
Day after first 
(or second) 
infection with 
BeG 
56 (D 
57 (2) 
58 (3) 
59 (4) 
60 (5) 
Mean corrected survival of S. Opkir,  turlum 
Group I  Group H  Group IH  Group IV 
Normal 
% 
50.7 
41.2 
52.3 
50.8 
33.1 
4 X  10' BCG 
% 
32.6 
31.8 
48.2 
33.4 
26.5 
5 X  107 BeG 
% 
34.0 
35.2 
51.4 
48.0 
11.5 
4X 10s+ 5 
X  107 BeG 
% 
42.1 
18.8 
20.8 
20.0 
8.4 
Coml~rison of means 
between groups 
i-m  ll-iV 
%  % 
16.7  --9.5 
6.0  13.0 
0.9  27.4* 
2.8  13.4" 
21.6"  18.1" 
* P  <  0.05. 
resulted in transient desensitization to PPD on days 1 to 3, but an enhanced 
response was obtained in those tested on day 4  (mean increase of 0.39 ram). 
The same dose of BCG produced no detectable hypersensitivity in previously 
uninfected mice during the course of the experiment. 
In  the  foregoing experiment,  the  vaccinated  animals  enjoyed no  striking 
advantage over normal controls in the  rapidity of onset  or magnitude  of the 
resistance generated in response to a  large inoculum of BCG. In the light of 
previous experience (2, 6), it was anticipated that prior exposure to BCG would 
have  produced  both  an  acceleration and  an  enhancement  of  the  resistance 
evoked by the second injection. Three factors may have combined to produce 
this unexpected result.  (a)  The irmnunized mice may have lost most of their 
capacity to respond anamnestically to reinfection, corresponding to the reduc- 
tion in their reactivity towards PPD. (b) The dose of organisms used in the rein- 
fecting inoculum was so large that it may have produced in normal mice a rapid 
and maximum response which could not be exceeded even by previously vac- 
cinated mice. (c) It is Conceivable that a large dose of BCG contributes a strong, It. V. BLANDEN,  M. J. LE~'FORD,  AND  G. B. MACKANESS  1091 
nonimmunological  stimulus  to  host  resistance  which  could  overshadow  the 
resistance generated by the specific immunological response to BCG. 
In view of the above considerations two additional  experiments were per- 
formed. In the first, a smaller reinfecting dose of BCG was used, and the animals 
TABLE V 
Indices of Resistance in Livers and Spleens of Mice after Primary or Secondary Infection with 
BCG (Experiment 2) 
Day of Listerla 
challenge after 
first (or second) 
BCG infection 
24  (I) 
25 (2) 
26  (3) 
27  (4) 
Group* 
II 
Ill 
IV 
II 
III 
IV 
Liver 
Index of resistance calculated 
between  groups 
I-ll 
I-lll 
I-IV 
H-IV 
0.95:~ 
o.81~ 
Spleen 
Index of resistance  calculated 
between groups 
I-H 
I-III 
0.885 
0.33 
1.8351: 
0.495 
1.085 
1.30~ 
1.625 
2.645 
0.96:~ 
o.64, 
1.745 
0.6~5 
1.23 
2.24 
H  1.17~ 
III  1.425 
IV  2.795 
II  0.76, 
III  t.22, 
IV  3.40~; 
0.74:~ 
0.65 
3.06 
0.695 
0.91 
2.72 
II-IV 
0.805 
M 
i.6o§ 
2.325 
m 
2.0351: 
* Group I, normal 
107 BCG. 
5  e <  0.01. 
§ P  <  0.05. 
controls; group II, lif  t BCG; group ILl,  107  BCG; group  IV, 104 + 
of the vaccinated group were introduced into the experiment at a  time when 
delayed hypersensitivity was at its height. The second experiment was designed 
to examine the possibility that a large inoculum of BCG causes nonimmunolog- 
ical stimulation of host resistance. 
Host Response to Reinfection  with BCG (Experiment 2) 
A large group of mice were infected intravenously with 104 viable BCG. After an interval 
of 23 days, half of these infected mice and half of a group of normal mice were inoculated in- 
travenously with 107 viable BCG to make four groups which corresponded with those of the 
previous experiment: group I, normal controls; group II, infected with 104 BCG 23 days pre- 
viously; group III, infected with 107 BCG; and group IV, infected with 104 BCG and rein- 1092  HOST  RESPONSE  TO CALMETTE-GU~RIN  BACILLUS 
fected with l0  T BCG. Mice of group II had a high level of delayed hypersensitivity; tuberculin 
tests produced a  mean increase in footpad thickness of 0.67 ram. Mice from each group were 
tested for Listeria  resistance at daily intervals for the first 4  days after injection of the re- 
infecting dose of BCG. 
The indices of resistance to L. monocytogenes in liver and spleen are shown in 
Table V. As in the earlier experiment, groups II, III and IV were compared with 
group I;  and group IV was also compared with group II. There was a slight 
and statistically insignificant increase of resistance to L. monocytogenes in the 
livers of the infected controls of group III on the 1st day. By day 2, this resis- 
tance had increased to 1.08 log units, a highly significant level. The indices of 
TABLE  VI 
Survival  of S. typhimurium in the Peritoneal Macrophages of Mice after Primary or Secondary 
Infection  with  BCG  (Experiment  2) 
Mean corrected survival of S. typhimurium 
Day after first 
(or second)  Group I  Group II  Group III  Group IV 
infection with 
BCG 
Normal  4X 10  aBCG  S X10'BCG  4X10  s+5  X 107 BCG 
24 (1) 
25  (2) 
26 (3) 
27 (4) 
% 
59.1 
72.2 
65.8 
50.2 
% 
57.2 
55.1 
51.7 
46.1 
% 
48.2 
73.7 
58.8 
78.4 
% 
27.8 
15.2 
14.9 
19.7 
Comparison  of means 
between  groups 
I-III  II-IV 
%  % 
10.9  29.4* 
--1.5  39.9* 
7.0  36.8* 
--28.2*  26.4* 
* P  <  0.05. 
resistance then remained fairly steady on days 3 and 4.  The indices of resis- 
tance in the livers of the reinfected mice of group IV (relative to group I) rose 
sharply on day 1, and after a slight drop on day 2 continued to increase to a 
value of 3.40 log units on day 4 (Fig. 2B). 
The spleen results were similar to those of the liver. Infected control mice of 
group III showed an increase in resistance on day 1 which did not rise appre- 
ciably higher on subsequent days. By contrast, resistance in the spleens of the 
reinfected mice of group IV increased steadily during the first 3 days, reaching 
a peak of 3.06 log units (Fig. 2D). When comparisons were made between the 
infected (group III) and uninfected (group I)  controls, and between the im- 
munized (group II) and reinfected mice (group IV), the index of resistance in 
mice of the last mentioned group was much greater in both liver and spleen on 
days 3 and 4 (Table V). 
The  bactericidal activity of the  peritoneal  cells  of the reinfected mice of 
group IV was greatly enhanced on the 1st day after the boosting dose of BCG 
(Table VI). This level of activity was steadily maintained for the remaining 3 R. V. BLANDEN,  M. J. LE~FFORD, AND  G. B. MACKANESS  1093 
days of the experiment. There was no significant variation between groups I, 
II, and III, except on day 4 when the survival of S. typhimurium in the macro- 
phages  of mice belonging to  the  group  of  infected controls  (group III) was 
TABLE VII 
Indices of Resistance in Livers and Spleens of Mice after Intravenous Challenge with Dead or 
Living BCG 
Day of L~s|crla 
challenge after 
BCG infection 
Group* 
II 
III 
IV 
II 
III 
IV 
II 
III 
IV 
II 
Ill 
IV 
Liver  Spleen 
Index of resistance calculated  Index of resistance calculated 
between groups  between groups 
I-H, I-III,  I-II, I-Ill, 
I-IV  I-IV 
--0.17 
--0.34 
0.25 
1.00 
0.74 
0.43 
1.81 
1.36 
0.42 
2.36 
1.67 
0.73 
I  p 
N.S. 
N.S. 
N.S. 
<0.01 
<0.05 
<0.05 
<0.01 
<0.01 
N.S. 
<0.01 
<0.01 
<0.05 
II 
III 
IV 
II 
III 
IV 
3.17  <0.01 
1.07  <0.01 
0.30  N.S. 
3.95  <0.01 
0.26  N.S. 
0.01  N.S. 
0.63 
0.37 
0.39 
1.93 
1.81 
0.50 
1.24 
0.81 
--0.22 
1.63 
0.37 
--0.12 
2.23 
0.69 
--0.01 
4.40 
0.34 
0.39 
p 
<0.05 
N.S. 
N.S. 
<0.01 
<0.01 
N.S. 
<0.01 
<0.01 
N.S. 
<0.01 
<0.05 
N.S. 
<0.01 
<0.01 
N.S. 
<0.01 
N.S. 
N.S. 
* Group I, normal controls; group II, 7 X  107 live BCG; group III, 7 X  10  ~ live BCG 
+  isoniazid; group IV, 7 X  107 heat-killed BCG. 
significantly  greater than normal. This odd result may have been due to random 
experimental variation. 
Comparison of the Response to Living and Dead BCG 
Four experimental groups of mice were treated  as follows: group I, uninfected controls; 
group II, mice infected intravenously with 7 X l0  T  viable BCG; group III, mice  infected as in 
II, but given isoniazid in their drinking water, 0.1 mg/ml, beginning 24 hr prior to infection 1094  HOST RESPONSE TO  CALM~TTE-GLrERIN  BACILLUS 
and continuing throughout  the experiment; group IV, mice injected intravenously with the 
same suspension of BCG after heat treatment at 56°C for 30 rain. A viable count on this sus- 
pension later revealed that the killing of BCG was incomplete so that each mouse received 
approximately 103 viable organisms along with 7 X 10  ¢ killed BCG. Resistance to intravenous 
+5  +5 
+4 
LIVER 
4-3 
=_ 
"6 
+1 
.t-4 
$PLEE 
III!1  I~  IItII  | 
12345  8  123  45  8 
Days after BCG injection: .living;  -~dead; &lNH-treated 
Fxo. 3. Progressive changes in the index of resistance to L. monocytogenes in the livers and 
spleens of mice given 7 ×  10  ¢ BCG on day 0. Those of group II received living BCG; those 
of group III received the same dose but were treated  continuously with isoniazid from one 
day prior to infection; and those of group IV received the same number of BCG after heat 
inactivation at 56°C for 30 rain. 
challenge with L. monocytogenes was determined on each group on days 1, 2, 3, 4, 5, and 8 
after inoculation with BCG, and delayed hypersensitivity to PPD was measured in 10 mice 
of each group after 10 days. 
The indices of resistance are set out in Table VII and illustrated in Fig.  3. 
The mice given 7  X  10  7 viable BCG behaved similarly during the first 3 days 
regardless of whether they were treated with isoniazid or not. Resistance in- 
creased sharply in the spleen for 2 days and then fell on the 3rd day. Thereafter, 
resistance continued to increase progressively in untreated mice and declined 
rapidly in those receiving isoniazid. The effects observed in the liver were sim- 
ilar except that resistance increased without interruption in the untreated ani- R.  V.  BLANDEN,  M.  J.  LEFFORD,  AND  G.  B.M.ACKANESS  1095 
mals of group II. In mice inoculated with predominantly heat-killed organisms 
(group  IV),  the trends followed those observed  in isoniazid-treated  animals, 
but at a much lower level. Resistance in the spleen of group IV animals did not 
achieve a level of significance and resistance in the liver was only sporadically 
significant at a low level (P <  0.05). 
At 10 days after injection of BCG, delayed hypersensitivity was detected in 
8 of 10 mice receiving live organisms (mean increase in foot thickness 0.11 mm) 
and in 4 of the 10 mice treated with isoniazid (0.05 mm); it was entirely absent 
from mice injected with dead BCG (group IV). 
Cytological Changes in the Peritoneal Macrophages of BCG-infected Mice 
In animals infected with 4 X  106 viable BCG, the highest levels of resistance 
to Listeria challenge were reached  after 12 to 15 days (Fig.  1). At this time, 
however, the free macrophages  of the peritoneal cavity were functionally nor- 
mal as measured by their capacity to inactivate S. typhimurium, and did not 
differ morphologically from the cells of normal mice. On the other hand, rein- 
fected animals and mice infected for the first time with much larger doses of 
BCG (10~-10  s viable units) showed striking changes in their peritoneal macro- 
phages.  The  ceils from heavily infected mice  were  seen,  by phase-contrast 
(Fig. 4) and electron microscopy (Fig. 5) to contain greatly increased  numbers 
of mitochondria and lysosomes. These activated macrophages  differed from 
normal ceils not merely in structural features; they were also found to spread 
more rapidly and extensively on glass when cultured in vitro. After 15 rain in- 
cubation at 37°C, all of the macrophages  recovered 2 days after a reinfecting 
dose of BCG were fully spread  (Fig. 6A), whereas the ceils of mice which had 
received only one dose of BCG took 3 hr or more to lose their rounded form 
(Fig. 6B). Phase-contrast micrographs  of macrophages  from infected mice also 
showed increased numbers of translucent vesicles (Fig. 4) which is indicative 
of increased pinocytic activity (7). 
These observations  suggest that the morphology of macrophages  and their 
behaviour in vitro faithfully reflect their microbicidal activity in vivo. 
DISCUSSION 
There is a substantial body of evidence in support of the hypothesis that im- 
munity to tuberculosis is ceil-mediated (8) and that this immunity is restricted 
to the sites of tuberculous inflammation (9). Grogg and Pearse (10) and Dan- 
nenberg,  Meyer, Esterly and Kambara (11), using histochemical  techniques, 
have shown  that macrophages  in the vicinity of tuberculous lesions contain 
more of certain lysosomal enzymes than cells situated more remotely. Further- 
more,  an increase  in lysosomal enzyme content is a consistent  feature of cell 
populations possessing enhanced microbicidal  ability (12), although no causal 
relationship has been established.  It follows that the level of host resistance in 1096  ]~OST  RESPONSE  TO  CAL~IETTE-GU~RIN BACILLUS 
tuberculosis depends on a combination of three factors: the number of tubercu- 
lous lesions, the size and cellularity of the lesions, and the microbicidal ability 
of the macrophages within and close to the lesions. 
In the present study, a heterologous organism,  L. manocytogenes was used to 
measure host resistance in the liver and spleen after primary and secondary in- 
fections with  BCG. L. monocytogenes was chosen  because it is a  facultative 
intracellular parasite which multiplies rapidly in vivo and is highly susceptible 
to inactivation by immune (or microbicidal)  macrophages (2, 6). It was hoped 
that  this  experimental  system would provide a  highly  sensitive measure  of 
host resistance, and this proved to be the case: indices of resistance as small as 
0.60 log units were often highly significant.  It can be objected that the resist- 
ance to L. monocytogenes was not directly analogous to resistance to BCG in 
these  experiments  because  the  immunologically  specific  components  in  the 
microbicidal action of immune macrophages have not been measured.  How- 
ever, leaving aside the requirement of specific opsonins  to facilitate the phago- 
cytosis of certain microorganisms  (e.g. Salmonella),  there is no evidence that 
the microbicidal action of macrophages has an immunologically specific compo- 
nent. On the contrary, there is strong evidence that the microbicidal action of 
these cells is entirely nonspecific  (6, 13, 14). 
In this study, it has been shown that  after infection with 4  X  106 viable 
BCG there was a  highly significant  increase in host resistance to L. monocy- 
togenes in both liver and spleen within 6 days, rising to a peak at 12-15 days, 
and then declining rapidly. There was a corresponding increase in the clearance 
of Listeria from the blood of these mice.  The changes after infection with the 
lower dose of BCG were much smaller,  a finding  which is consistent with the 
concept of local immunity. The relationship between resistance and the growth 
of BCG is of considerable interest. The early phase of resistance to L. monoay- 
togenes (3-12 days) coincided with the growth of BCG in liver and spleen, and 
peak resistance  (12-15  days) was reached  at  a  time when multiplication  of 
BCG ceased (Fig. 1). These associations support the hypothesis that resistance 
to L. monocytogenes accurately reflects a parallel  resistance to BCG. However, 
during  the period of declining  resistance  to Listeria  (15-28 days)  there was 
continuing inhibition of the growth of BCG. An explanation for this apparent 
anomaly lies in the fact that macrophages are affected systemically only during 
periods of intense antigenic stimulation (2, 9). As lesions develop, the organisms 
within them become increasingly  confined and their stimulatory effect is largely 
restricted to phagocytes within the lesions  or close by. This concept of local 
immunity, which was clearly enunciated by Dannenberg (9), helps to explain 
why resistance to BCG is sustained, while  resistance to a  Listeria  challenge 
declines. 
The microbicidal ability of peritoneal macrophage was assayed with opsonized 
S. typhimurium as the target organism. Neither dose of BCG caused any en- 
hancement of bacterial killing  by peritoneal macrophages during primary in- R.  v.  BLANDEN,  M.  J.  L~rORD,  A~U)  o.  B.  ~AC~SS  1097 
fection. This result  is  at variance  with  that  obtained in mice  infected with 
L. monocytogenes,  in whom an increase in microbicidal activity of the peritoneal 
macrophages was evident from the 4th day of infection and persisted up to a 
month (15, 16). This discrepancy may merely reflect a difference in the degree 
of antigenic stimulation  since  a  reinfecting  dose of BCG or a  large primary 
intravenous challenge  with 10  8 viable BCG regularly produced changes in the 
peritoneal cells associated with a marked increase in microbicidal ability. This is 
further evidence that a systemic effect on host macrophages occurs only under 
conditions of intense antigenic stimulation. 
The present observations are reminiscent of less extensive studies made in 
mice infected with Brucdla abortus (6). The development of host resistance in 
Brucdla-infected  mice follows a similar time course, but once established, resist- 
ance is more incisively effective against Br. abortus than  is the antibacterial 
mechanism developed against BCG. This again implies  that BCG is relatively 
insusceptible to inactivation. As in BruceUa infection, there was a phase during 
BCG infection which was associated with partial loss of delayed hypersensitiv- 
ity. It coincided with the onset of the decline in the number of viable bacteria 
in the tissues, suggesting  that the release of antigen from inactivated bacteria 
causes desensitization. The transient loss of hypersensitivity after the second 
intravenous injection of BCG is perhaps analogous. 
It was anticipated that host resistance to L. monovytogenes would be initiated 
more rapidly in mice receiving their second dose of BCG than in mice receiving 
their first dose. In the first experiment, the immunized mice did not respond 
more rapidly than normal mice to a large BCG challenge  (Fig. 2A, 2C), though 
a  high level of resistance was reached by the 4th day. Previous studies had 
dearly shown that living  organisms (L. monocytogenes, Br. abortus, BCG) will 
augment the host's defenses at an accelerated rate when injected into homolo- 
gonsly immunized mice (2, 6). This discrepancy calls for further comment. 
It has long been suspected on circumstantial evidence (17) that the induction 
of acquired cellular resistance is in some way dependent on the type of immune 
response which leads to the state of delayed hypersensitivity. Recent studies 
in this laboratory on the transfer of specific immunity to L. monocytogenes from 
immune donors to normal animals have demonstrated that antibacterial resist- 
ance does in fact depend on a state of immunological  reactivity which can be 
transferred with living lymphoid cells but not with serum (18, 19). This indicates 
unambiguously that  acquired  cellular  resistance  arises  from  a  cell-mediated 
form of immunity, and places it in a  category with delayed-type hypersensi- 
tivity. It may be relevant, therefore, that  the immunized animals of Experi- 
ment 1 had lost much of their delayed hypersensitivity to PPD at the time of 
reinfection.  For this reason the experiment was repeated in order to reinfect 
mice while still at the height of their reactivity to tuberculo-proteins. The level 
of delayed hypersensitivity was not  the  only variation  introduced  into  the 
second reinfection experiment, the other was a reduction in the size of the second 1098  HOST RESPONSE  TO CAL~ETTE-GUERIN  BACILLUS 
dose of BCG. This appeared necessary in view of the rapidity of onset and the 
magnitude of the resistance  generated during primary infection  with a  large 
dose of BCG (Figs. 2A, 2C, group III). 
The increase of resistance in the livers and spleens of immunized mice (indices 
of resistance II-IV, Table V) during the first 2 days was again not conspicuously 
greater than in mice receiving their first dose of BCG (indices of resistance I- 
III, Table V).  Considered alone, this might suggest that the level of delayed 
hypersensitivity  had no influence on the rapidity with which host macrophages 
develop increased activity. The experiments  in which the microbicidal ability 
of the peritoneal  macrophages  was measured provide  contrary evidence.  In 
Experiment 1 enhancement of the microbicidal  ability of the peritoneal  cells 
was inapparent until the 3rd day, as compared to the first day in Experiment 2. 
These results are of greater value than those obtained from the liver and spleen, 
since resistance in the latter organs may have been initiated by the nonimmuno- 
logical antimicrobial effects of BCG (see next section). On balance, the evidence 
favors the hypothesis that there is an association between the level of delayed 
hypersensitivity and the rate at which resistance develops. 
A feature of the above experiments was the very rapid onset of resistance in 
the liver and spleen after a primary BCG infection (Figs. 2 and 3, group III). 
Although it has been shown that the primary antibody response to some anti- 
gens can be detected within 24 hr of challenge (20, 21), it seemed improbable 
that this would be the case in cell-mediated  immunity after BCG infection. 
The other possibility was that the early phase of host resistance might be due 
to a nonspecific stimulation of the macrophages  in the liver and spleen, quite 
independent of the immune response to living organisms. During primary BCG 
infection there was a rapid rise in resistance during the first 2 days which re- 
mained steady during days 3 and 4. From day 4, there was a progressive in- 
crease of resistance until peak immunity was obtained (Figs.  1, 2, and 3). The 
biphasic nature of the early response was more clearly seen in the spleen than 
in the liver. When the nature of the early host response to primary infection was 
examined experimentally (Table VII), it was found that heat-killed BCG pro- 
duced no significant increase in host resistance. The response to live BCG was 
very similar  to that obtained in earlier experiments  (Figs.  1,  2, and 3).  The 
treatment of infected mice with isoniazid caused an abrupt interruption to the 
progressive development of resistance on the 3rd and 4th days in the spleen and 
liver, respectively  (Fig. 3). This could be explained by the lag of 72 hr which is 
sometimes  found before the bactericidal  action of isoniazid takes effect  (22). 
Alternatively, live tubercle bacilli may contain or elaborate in vivo a heat-labile 
substance which nonspecifically enhances host resistance. 
If living  organisms  do produce  a  heat-labile  factor which  stimulates host 
resistance nonspecifically, and it continues to be produced by microorganisms 
growing in vivo, this would imply that the resistance mechanism we have been 
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because it ignores the findings of earlier studies which showed that cellular re- 
sistance to infection is increased (16) or reestablished  (2) in previously infected 
animals only by the microbial  species with which the animal was previously 
vaccinated. These findings, as well as the recent demonstration (18, 19)  that 
the cellular immunity transferrable with spleen cells is specific for the infective 
agent used to immunize the donor,  point strongly to the conclusion that the 
mechanism of resistance  is the outcome of an immunological  event. The ac- 
celerated onset of resistance in the vaccinated animals of the second reinfection 
experiment  reported in this paper constitutes further evidence of an immuno- 
logical basis for the resistance  to heterologous  organisms developed by BCG- 
infected mice. Moreover, the failure of animals to develop delayed-type hyper- 
sensitivity or any significant increase in resistance to a Listeria  challenge when 
injected with large numbers of heat-killed BCG points clearly to the involve- 
ment of an immunological  process  in the induction of the cellular  changes 
which make for increased host resistance. 
SUMMARY 
Heterologous organisms (L. monocytogenes and S. typhimurium) were used to 
study the rate of development, magnitude, and persistence of the antimicrobial 
resistance engendered in mice by vaccination with BCG. These same methods 
were used to investigate the influence of prior vaccination on the host response 
to reinfection. 
The rate of onset and magnitude of the resistance produced by BCG varied 
with the vaccinating dose. Increased resistance  was detected within 48 hr of 
injecting large numbers of BCG (approximately l0  s viable units), but concur- 
rent treatment with isoniazid  interrupted its further development.  An equal 
number of heat-killed organisms failed to influence host resistance significantly. 
The development of tuberculin sensitivity was also dependent upon the con- 
tinued survival of the immunizing population of BCG. 
When vaccinated mice were reinfected  with BCG, host resistance in spleen 
and liver was rapidly augmented to the accompaniment of striking changes in 
the morphology and microbicidal activity of the peritoneal macrophages. These 
changes occurred most rapidly in mice with a high level of delayed hypersensi- 
tivity at the time of reinfection. 
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FIG. 4.  Phase-contrast appearance of peritoneal macrophages from  normal mice 
(A) and BCG-infected mice (B) after incubation for 24 hr in Hanks' BSS containing 
5% fetal calf serum. The cells are conspicuously different in size, tendency to spread, 
content of mitochondria (filamentious bodies) and lysosomes (phase-dense bodies), 
and in pinocytic activity (phase-lucent vesicles). Only half of an activated macrophage 
is  contained in  the field depicting cells from  a  BCG-infected animal. These were 
obtained 14 days after the intravenous injection of 10  s viable units  X  1900 1103 J 10~  HOST  RESPONSE  TO  CALMETTE-GLrERIN  BACILLUS R.  V.  BLANDEN~ M.  J.  LEFFORD, AND  G.  B.  MACKANESS  1105 
FIG. 5.  Ultrastructural features of the peritoneal macrophages illustrated in Fig. 4. 
The most conspicuous differences  are the greater size and content of organelles in the 
cells from a BCG-infected animal (B) when compared with normal cells (A). One of 
the latter contains an ingested organism ; this was part of a largely negative attempt to 
demonstrate a  greater than normal capacity for digestion on the part of  activated 
macrophages.  Glutaraldehyde-osmium tetroxide  fixation; uranyl acetate  and  lead 
citrate stain. Normal and immune cells are magnified equally. 1106  HOST RESPONSE TO CALMETTE-GUERIN BACILLUS 
FIe,. 6.  Cultural  characteristics  of  peritoneal  macrophages  from:  BCG-infected 
mice given 1  >(  104 BCG 25 days previously (A)  and similarly vaccinated animals 
given a second injection of 1 X  107 BCG 48 hr prior to recovery of cells. Only half of 
the cells from vaccinated but unchallenged mice had begun to spread into elongated 
forms when fixed after 3 hr of incubation  at 37°C, whereas all the cells of the reinfected 
animal were spread when fixed after only 15 min of incubation at 37°C. There is also 
a characteristic difference  in the contours of normal and stimulated cells. The latter 
tend to spread circumferentially. Cultures prepared from  animals of  Experiment 2 
of Fig. 2 and Tables V and VI. (Phase-contrast,  ×  470). 1107 